AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TTK | Ann: Resignation of Chief Transformation Officer | 16/04/18 | 0 | 23 | |||
|
|||||||
| TTK | Ann: Appointment of Chief Technology Officer | 16/04/18 | 0 | 23 | |||
|
|||||||
| TTK | Ann: Change in Officers | 05/04/18 | 0 | 22 | |||
|
|||||||
| TTK | Ann: Retirement of Director: Geoff Davis | 03/04/18 | 0 | 20 | |||
|
|||||||
| TTK | Ann: TeamTalk 1H18 Interim Report | 27/03/18 | 0 | 38 | |||
|
|||||||
| TTK | Ann: D&O Ongoing Disclosure – David Struthers | 20/03/18 | 0 | 36 | |||
|
|||||||
| TTK | Ann: Ongoing Disclosure Notices - Multiple | 14/03/18 | 0 | 31 | |||
|
|||||||
See All Discussions
NZX News